伊维菌素的广泛分布在墨西哥被证明对 COVID-19 有效
一个在抗击 COVID 大流行的战争中取得显著成功的国家
但几乎没有得到全球媒体的报道，是墨西哥。
2021 年 1 月 22 日，墨西哥城市长 Claudia Scheinbaum，
举行了电视直播新闻发布会，她谈到了 12 月伊维菌素分配的积极结果。
新闻稿发布后，
整个墨西哥的每个人都可以使用这些试剂盒，并对伊维菌素在全国范围内的使用结果进行监测。
令人惊讶的是，在大量分发伊维菌素后，
墨西哥的每一个 COVID 指标都有所改善。
在 18 周的时间里，
COVID病例、住院人数和死亡人数持续下降，
5 月 14 日，市长举行了另一场电视新闻发布会，分享了长达数月的竞选活动的积极成果。
COVID cases in Mexico
exploded in April 2020, the first hot spots flaring up along the northern border with the United States, in Mexico City and Quintana Roo, a popular tourist destination in the Caribbean.
At the beginning of the pandemic,
Mexico took recommendations and followed protocol set forth by the WHO and watched the virus spread from state to state, engulfing the entire country.
First COVID Outbreak in Mexico
On June 10,
the Spanish-speaking media began reporting on the success that Peru was having in controlling the virus using ivermectin as a treatment.
Mexico
was in the middle of its worst peak of cases and deaths with records breaking daily, and interest in the drug – as well as sales – rose dramatically.
On June 20,
the pan-American WHO (OPS/OMS) issued a statement strongly opposing the use of ivermectin.
Additionally,
other media sources started publishing anti-ivermectin articles all over Mexico.
And as the number of deaths slowly decreased, interest in ivermectin subsequently died down.
In October 2020,
cases in Mexico began spiking again;
the outbreak this time started in Chihuahua, the state on the border of Texas.
Texas was also experiencing an outbreak at this time, so it’s likely that the cases in Mexico were sparked in the US.
From Chihuahua, cases spread south and into Mexico City igniting the worst outbreak yet.
Mexico City
was an inferno of COVID cases and death, and health workers rushed to the capital city from all over the country to help.
Determined to stop the spread at any cost, Mexico City officials
held a meeting at the end of December, 2020, and invited the Instituto Mexicano del Seguro Social (IMSS) among other groups of doctors.
Together,
they decided to begin distribution of ivermectin kits in Mexico City and Mexico State
to anyone who tested positive for COVID and wanted to take the drug,
and to closely monitor hospitalizations to keep tabs on ivermectin’s efficacy.
The kits distributed included ivermectin, aspirin and paracetamol.
Between the end of November 2020 and the end of January 2021,
more than 200,000 people tested positive for COVID, and of these, nearly 80,000 used the ivermectin kits.
Results showed up to 76% reduction in hospitalization in the group that was taking ivermectin.